Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication?

Matrisciano F, Panaccione I, Zusso M, Giusti P, Tatarelli R, Iacovelli L, Mathé AA, Gruber SH, Nicoletti F, Girardi P.

Mol Psychiatry. 2007 Aug;12(8):704-6. No abstract available.

PMID:
17653204
2.

Metabotropic glutamate receptors and neuroadaptation to antidepressants: imipramine-induced down-regulation of beta-adrenergic receptors in mice treated with metabotropic glutamate 2/3 receptor ligands.

Matrisciano F, Scaccianoce S, Del Bianco P, Panaccione I, Canudas AM, Battaglia G, Riozzi B, Ngomba RT, Molinaro G, Tatarelli R, Melchiorri D, Nicoletti F.

J Neurochem. 2005 Jun;93(5):1345-52.

3.

Defective group-II metaboropic glutamate receptors in the hippocampus of spontaneously depressed rats.

Matrisciano F, Caruso A, Orlando R, Marchiafava M, Bruno V, Battaglia G, Gruber SH, Melchiorri D, Tatarelli R, Girardi P, Mathè AA, Nicoletti F.

Neuropharmacology. 2008 Sep;55(4):525-31. doi: 10.1016/j.neuropharm.2008.05.014.

PMID:
18590921
4.

Influence of imipramine treatment on the group I of metabotropic glutamate receptors in CA1 region of hippocampus.

Pałucha A, Brański P, Tokarski K, Bijak M, Pilc A.

Pol J Pharmacol. 1997 Nov-Dec;49(6):495-7.

PMID:
9566055
5.

A novel mGlu4 selective agonist LSP4-2022 increases behavioral despair in mouse models of antidepressant action.

Podkowa K, Rzeźniczek S, Marciniak M, Acher F, Pilc A, Pałucha-Poniewiera A.

Neuropharmacology. 2015 Oct;97:338-45. doi: 10.1016/j.neuropharm.2015.05.039.

PMID:
26074092
6.

Effect of chronic antidepressant or electroconvulsive shock treatment on mGLuR1a immunoreactivity expression in the rat hippocampus.

Bajkowska M, Brański P, Smiałowska M, Pilc A.

Pol J Pharmacol. 1999 Nov-Dec;51(6):539-41.

PMID:
10817534
7.

Antidepressant treatment influences group I of glutamate metabotropic receptors in slices from hippocampal CA1 region.

Pilc A, Brański P, Pałucha A, Tokarski K, Bijak M.

Eur J Pharmacol. 1998 May 15;349(1):83-7.

PMID:
9669500
8.

Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge.

Lorrain DS, Schaffhauser H, Campbell UC, Baccei CS, Correa LD, Rowe B, Rodriguez DE, Anderson JJ, Varney MA, Pinkerton AB, Vernier JM, Bristow LJ.

Neuropsychopharmacology. 2003 Sep;28(9):1622-32.

9.

Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.

Koike H, Fukumoto K, Iijima M, Chaki S.

Behav Brain Res. 2013 Feb 1;238:48-52. doi: 10.1016/j.bbr.2012.10.023.

PMID:
23098797
10.
11.

In vivo modulation of extracellular hippocampal glutamate and GABA levels and limbic seizures by group I and II metabotropic glutamate receptor ligands.

Smolders I, Lindekens H, Clinckers R, Meurs A, O'Neill MJ, Lodge D, Ebinger G, Michotte Y.

J Neurochem. 2004 Mar;88(5):1068-77.

12.
15.

Are compounds acting at metabotropic glutamate receptors the answer to treating depression?

Palucha A.

Expert Opin Investig Drugs. 2006 Dec;15(12):1545-53. Review.

PMID:
17107280
16.

Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression?

Réus GZ, Stringari RB, Kirsch TR, Fries GR, Kapczinski F, Roesler R, Quevedo J.

Brain Res Bull. 2010 Apr 5;81(6):585-9. doi: 10.1016/j.brainresbull.2009.11.013.

PMID:
19954760
17.

Hippocampal astrocytes are necessary for antidepressant treatment of learned helplessness rats.

Iwata M, Shirayama Y, Ishida H, Hazama GI, Nakagome K.

Hippocampus. 2011 Aug;21(8):877-84. doi: 10.1002/hipo.20803.

PMID:
20572198
19.

Pharmacology and neuroprotective actions of mGlu receptor ligands.

O'Neill MJ.

Dev Med Child Neurol Suppl. 2001 Mar;86:13-5. No abstract available.

PMID:
11268716
20.

Supplemental Content

Support Center